RxDoctor Payments Data

Cynthia Branson

Family · Anderson, INNPI 1982167706

Payments from drug & device makers

$672in general payments, 2019–2025

Across 38 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$156
  • Pfizer$92
  • Astellas Pharma US Inc$52
  • Gilead$47
  • Amgen$37
  • Sanofi Pasteur Inc.$32
  • plus $255 from 15 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$672 in reported general payments places this provider in the 60th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$813
Medicare patients
21
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$51,923
FarxigaDapagliflozin Propanediol16$15,897
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$7,298
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl35$5,245
Albuterol Sulfate HfaAlbuterol Sulfate132$4,611
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$3,821
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$2,192
Gabapentin121$1,573
Montelukast Sodium25$1,431
Buprenorphine Hcl27$1,320
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,134
Ventolin HfaAlbuterol Sulfate14$896
Hydroxyzine Hcl21$851
Omeprazole69$805
Atorvastatin Calcium143$706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$24$51,92355 claims
AstraZenecaFarxiga$14$15,89716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,392 family providers in Indiana.

Other family in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →